Cauda equina injury
Conditions
Interventions
The test cycle:autologous bone marrow mononuclear cells
Controlled cycle:Conventional treatment
Sponsors
Xiangyang No.1 People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) The diagnostic is cauda equina injury; (2) Older than 18 years, less than 75 years; (3) The cause of cauda equina injury has been removed and the disease is in a stable period; (4) The type of cauda equina injury was incomplete or the cauda equina was dividing but had been sutured; (5) Good compliance, willing to cooperate with the study, and patients signed informed consent
Exclusion criteria
Exclusion criteria: (1) The menstrual period was 3 days before surgery for female patients; (2) The puncture site has the possibility of infection or poor skin conditions; (3) Patients with associated malignant tumors; (4) Any disease known to seriously affect the immune system, or advanced blood system, etc.; (6) Women who are pregnant or breastfeeding, or who plan to become pregnant during the study period; (5) People are inability to communicate properly and incapacitation,or psychiatric conditions that may affect programme compliance,or at risk of suicide, or with a history of alcohol or illicit drug abuse; (6) People have participated in or are participating in other clinical trials within 3 months before enrollment; (7) The researcher does not consider it appropriate to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ASIA2000??; | — |
Secondary
| Measure | Time frame |
|---|---|
| Bladder residual urine measurement;VAS;Barthel ADL;Functional Independence Measure, FIM;Safety outcome indicator; | — |
Countries
China
Contacts
Public ContactBin Pei
Xiangyang No.1 People's Hospital
Outcome results
None listed